Status: current, Defined. Date: 31-Jan 2019. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3740409012 | Gemtuzumab ozogamicin only product in parenteral dose form | en | Synonym | Active | Case insensitive | SNOMED CT core |
3740410019 | Product containing only gemtuzumab ozogamicin in parenteral dose form (medicinal product form) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Gemtuzumab ozogamicin only product in parenteral dose form | Is a | Gemtuzumab ozogamicin only product | true | Inferred relationship | Some | ||
Gemtuzumab ozogamicin only product in parenteral dose form | Count of base of active ingredient | 1 | false | Inferred relationship | Some | ||
Gemtuzumab ozogamicin only product in parenteral dose form | Is a | Gemtuzumab ozogamicin-containing product in parenteral dose form | true | Inferred relationship | Some | ||
Gemtuzumab ozogamicin only product in parenteral dose form | Has active ingredient | Gemtuzumab ozogamicin | true | Inferred relationship | Some | 1 | |
Gemtuzumab ozogamicin only product in parenteral dose form | Has manufactured dose form | Parenteral dose form | true | Inferred relationship | Some | ||
Gemtuzumab ozogamicin only product in parenteral dose form | Plays role | Antineoplastic therapeutic role | true | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Gemtuzumab ozogamicin 5 mg powder for solution for injection vial | Is a | False | Gemtuzumab ozogamicin only product in parenteral dose form | Inferred relationship | Some | |
Gemtuzumab ozogamicin 5 mg powder for solution for infusion and/or injection vial | Is a | True | Gemtuzumab ozogamicin only product in parenteral dose form | Inferred relationship | Some |
Reference Sets
Description inactivation indicator reference set
REPLACED BY association reference set